Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Terence Flynn is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/06/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | ARVN | Buy Now | Arvinas | $6.57 | 82.65% | Terence Flynn66% | $48 → $12 | Maintains | Equal-Weight | Get Alert |
| 03/11/2025 | BNTX | Buy Now | BioNTech | $88.05 | 57.86% | Terence Flynn66% | $145 → $139 | Maintains | Overweight | Get Alert |
| 03/07/2025 | BHVN | Buy Now | Biohaven | $18.59 | 238.89% | Terence Flynn66% | $69 → $63 | Maintains | Overweight | Get Alert |
| 02/18/2025 | RCUS | Buy Now | Arcus Biosciences | $6.87 | 263.9% | Terence Flynn66% | $36 → $25 | Maintains | Overweight | Get Alert |
| 02/14/2025 | OGN | Buy Now | Organon | $13.05 | 22.62% | Terence Flynn66% | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 02/14/2025 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | -2.94% | Terence Flynn66% | $30 → $32 | Maintains | Underweight | Get Alert |
| 02/05/2025 | MRK | Buy Now | Merck & Co | $81.60 | 29.9% | Terence Flynn66% | $113 → $106 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $186.99 | 27.81% | Terence Flynn66% | $224 → $239 | Maintains | Overweight | Get Alert |
| 02/03/2025 | NRIX | Buy Now | Nurix Therapeutics | $9.50 | 78.95% | Terence Flynn66% | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 01/27/2025 | NTLA | Buy Now | Intellia Therapeutics | $6.59 | 66.92% | Terence Flynn66% | $56 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/23/2025 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 6.16% | Terence Flynn66% | $175 → $163 | Maintains | Equal-Weight | Get Alert |
| 01/21/2025 | MRK | Buy Now | Merck & Co | $81.60 | 38.48% | Terence Flynn66% | $123 → $113 | Maintains | Equal-Weight | Get Alert |
| 11/12/2024 | ABBV | Buy Now | AbbVie | $186.99 | 19.79% | Terence Flynn66% | $231 → $224 | Maintains | Overweight | Get Alert |
| 11/12/2024 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | -28.8% | Terence Flynn66% | $36 → $39 | Maintains | Underweight | Get Alert |
| 11/01/2024 | MRK | Buy Now | Merck & Co | $81.60 | 50.74% | Terence Flynn66% | $130 → $123 | Maintains | Equal-Weight | Get Alert |
| 10/31/2024 | ABBV | Buy Now | AbbVie | $186.99 | 23.54% | Terence Flynn66% | $218 → $231 | Maintains | Overweight | Get Alert |
| 10/30/2024 | PFE | Buy Now | Pfizer | $22.93 | 35.19% | Terence Flynn66% | $30 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/16/2024 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 13.98% | Terence Flynn66% | $169 → $175 | Maintains | Equal-Weight | Get Alert |
| 10/11/2024 | PFE | Buy Now | Pfizer | $22.93 | 30.83% | Terence Flynn66% | $31 → $30 | Maintains | Equal-Weight | Get Alert |
| 09/24/2024 | BNTX | Buy Now | BioNTech | $88.05 | 64.68% | Terence Flynn66% | $93 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/23/2024 | GPCR | Buy Now | Structure Therapeutics | $15.00 | 686.67% | Terence Flynn66% | → $118 | Initiates | → Overweight | Get Alert |
| 08/27/2024 | LLY | Buy Now | Eli Lilly | $717.01 | 54.25% | Terence Flynn66% | $1106 → $1106 | Reiterates | Overweight → Overweight | Get Alert |
| 08/12/2024 | ABBV | Buy Now | AbbVie | $186.99 | 16.58% | Terence Flynn66% | $211 → $218 | Maintains | Overweight | Get Alert |
| 07/31/2024 | PFE | Buy Now | Pfizer | $22.93 | 35.19% | Terence Flynn66% | $29 → $31 | Maintains | Equal-Weight | Get Alert |
| 07/24/2024 | BHVN | Buy Now | Biohaven | $18.59 | 212% | Terence Flynn66% | → $58 | Initiates | → Overweight | Get Alert |
| 07/23/2024 | ALMS | Buy Now | Alumis | $9.70 | 271.13% | Terence Flynn66% | → $36 | Initiates | → Overweight | Get Alert |
| 07/18/2024 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 10.07% | Terence Flynn66% | $167 → $169 | Maintains | Equal-Weight | Get Alert |
| 07/11/2024 | RPRX | Buy Now | Royalty Pharma | $31.00 | 64.52% | Terence Flynn66% | $48 → $51 | Maintains | Overweight | Get Alert |
| 07/11/2024 | ABBV | Buy Now | AbbVie | $186.99 | 4.82% | Terence Flynn66% | $191 → $196 | Maintains | Overweight | Get Alert |
| 07/11/2024 | MRK | Buy Now | Merck & Co | $81.60 | 64.22% | Terence Flynn66% | $132 → $134 | Maintains | Equal-Weight | Get Alert |
| 07/11/2024 | AMGN | Buy Now | Amgen | $294.00 | 3.06% | Terence Flynn66% | $310 → $303 | Maintains | Equal-Weight | Get Alert |
| 07/11/2024 | UTHR | Buy Now | United Therapeutics | $292.46 | 9.76% | Terence Flynn66% | $310 → $321 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/05/2024 | LLY | Buy Now | Eli Lilly and Co | $717.01 | 42.68% | Terence Flynn66% | $1023 → $1023 | Maintains | Overweight | Get Alert |
| 05/13/2024 | RCUS | Buy Now | Arcus Biosciences | $6.87 | 482.24% | Terence Flynn66% | $38 → $40 | Maintains | Overweight | Get Alert |
| 05/06/2024 | BPMC | Buy Now | Blueprint Medicines | $81.68 | 105.68% | Terence Flynn66% | $121 → $168 | Maintains | Buy | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $294.00 | 5.44% | Terence Flynn66% | $271 → $310 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | PFE | Buy Now | Pfizer | $22.93 | 26.47% | Terence Flynn66% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 8.77% | Terence Flynn66% | $168 → $167 | Maintains | Equal-Weight | Get Alert |
| 03/31/2024 | PFE | Buy Now | Pfizer | $22.93 | 26.47% | Terence Flynn66% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
| 02/26/2024 | NRIX | Buy Now | Nurix Therapeutics | $9.50 | 5.26% | Terence Flynn66% | $9 → $10 | Maintains | Equal-Weight | Get Alert |
| 02/26/2024 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | 45.59% | Terence Flynn66% | $46 → $48 | Maintains | Underweight | Get Alert |
| 02/26/2024 | CCCC | Buy Now | C4 Therapeutics | $1.30 | 515.38% | Terence Flynn66% | $1 → $8 | Maintains | Equal-Weight | Get Alert |
| 02/16/2024 | LLY | Buy Now | Eli Lilly | $717.01 | 32.49% | Terence Flynn66% | $805 → $950 | Maintains | Overweight | Get Alert |
| 02/07/2024 | AMGN | Buy Now | Amgen | $294.00 | -5.44% | Terence Flynn66% | $281 → $278 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 10.07% | Terence Flynn66% | $170 → $169 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | RCUS | Buy Now | Arcus Biosciences | $6.87 | 409.46% | Terence Flynn66% | $38 → $35 | Maintains | Overweight | Get Alert |
| 11/13/2023 | ARVN | Buy Now | Arvinas | $6.57 | 204.41% | Terence Flynn66% | $32 → $20 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | 27.39% | Terence Flynn66% | $43 → $42 | Maintains | Underweight | Get Alert |
| 11/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $6.59 | 1189.83% | Terence Flynn66% | $90 → $85 | Maintains | Overweight | Get Alert |
| 11/09/2023 | RPRX | Buy Now | Royalty Pharma | $31.00 | 83.87% | Terence Flynn66% | $54 → $57 | Maintains | Overweight | Get Alert |
| 11/06/2023 | CCCC | Buy Now | C4 Therapeutics | $1.30 | -23.08% | Terence Flynn66% | $3 → $1 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/02/2023 | UTHR | Buy Now | United Therapeutics | $292.46 | 7.37% | Terence Flynn66% | $318 → $314 | Maintains | Overweight | Get Alert |
| 11/01/2023 | PFE | Buy Now | Pfizer | $22.93 | 61.36% | Terence Flynn66% | $39 → $37 | Maintains | Equal-Weight | Get Alert |
| 11/01/2023 | AMGN | Buy Now | Amgen | $294.00 | -1.02% | Terence Flynn66% | $300 → $291 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | ABBV | Buy Now | AbbVie | $186.99 | 4.82% | Terence Flynn66% | $193 → $196 | Maintains | Overweight | Get Alert |
| 10/27/2023 | MRK | Buy Now | Merck & Co | $81.60 | 44.61% | Terence Flynn66% | $115 → $118 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | -8.72% | Terence Flynn66% | $56 → $50 | Maintains | Underweight | Get Alert |
| 10/18/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 11.37% | Terence Flynn66% | $174 → $171 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | PFE | Buy Now | Pfizer | $22.93 | 70.08% | Terence Flynn66% | $40 → $39 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | AMGN | Buy Now | Amgen | $294.00 | 2.04% | Terence Flynn66% | → $300 | Reinstates | → Equal-Weight | Get Alert |
| 10/11/2023 | RPRX | Buy Now | Royalty Pharma | $31.00 | 74.19% | Terence Flynn66% | $53 → $54 | Maintains | Overweight | Get Alert |
| 10/11/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | $25 → $12 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | OGN | Buy Now | Organon | $13.05 | 68.61% | Terence Flynn66% | $27 → $22 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | MRK | Buy Now | Merck & Co | $81.60 | 40.93% | Terence Flynn66% | $116 → $115 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 13.33% | Terence Flynn66% | $172 → $174 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 2.24% | Terence Flynn66% | $57 → $56 | Maintains | Underweight | Get Alert |
| 10/11/2023 | ABBV | Buy Now | AbbVie | $186.99 | 3.21% | Terence Flynn66% | $189 → $193 | Maintains | Overweight | Get Alert |
| 08/31/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 12.02% | Terence Flynn66% | $187 → $172 | Maintains | Equal-Weight | Get Alert |
| 08/14/2023 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | 30.42% | Terence Flynn66% | $42 → $43 | Maintains | Underweight | Get Alert |
| 08/14/2023 | ARVN | Buy Now | Arvinas | $6.57 | 387.06% | Terence Flynn66% | $35 → $32 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | RPRX | Buy Now | Royalty Pharma | $31.00 | 70.97% | Terence Flynn66% | $52 → $53 | Maintains | Overweight | Get Alert |
| 08/09/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | $26 → $25 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | OGN | Buy Now | Organon | $13.05 | 106.93% | Terence Flynn66% | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 08/08/2023 | RCUS | Buy Now | Arcus Biosciences | $6.87 | 453.13% | Terence Flynn66% | $40 → $38 | Maintains | Overweight | Get Alert |
| 08/03/2023 | UTHR | Buy Now | United Therapeutics | $292.46 | 8.73% | Terence Flynn66% | $316 → $318 | Maintains | Overweight | Get Alert |
| 08/03/2023 | BPMC | Buy Now | Blueprint Medicines | $81.68 | 1.62% | Terence Flynn66% | $93 → $83 | Maintains | Buy | Get Alert |
| 08/02/2023 | PFE | Buy Now | Pfizer | $22.93 | 74.44% | Terence Flynn66% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | MRK | Buy Now | Merck & Co | $81.60 | 42.16% | Terence Flynn66% | $109 → $116 | Maintains | Equal-Weight | Get Alert |
| 07/21/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 21.79% | Terence Flynn66% | $187 → $187 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/21/2023 | PFE | Buy Now | Pfizer | $22.93 | 83.17% | Terence Flynn66% | $43 → $42 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 7.71% | Terence Flynn66% | $59 → $59 | Reiterates | Underweight → Underweight | Get Alert |
| 07/17/2023 | NRIX | Buy Now | Nurix Therapeutics | $9.50 | 26.31% | Terence Flynn66% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | RPRX | Buy Now | Royalty Pharma | $31.00 | 67.74% | Terence Flynn66% | $52 → $52 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | $26 → $26 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | PFE | Buy Now | Pfizer | $22.93 | 87.53% | Terence Flynn66% | $43 → $43 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | MRK | Buy Now | Merck & Co | $81.60 | 33.58% | Terence Flynn66% | $109 → $109 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 21.79% | Terence Flynn66% | $183 → $187 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 7.71% | Terence Flynn66% | $59 → $59 | Reiterates | Underweight → Underweight | Get Alert |
| 07/11/2023 | ABBV | Buy Now | AbbVie | $186.99 | -2.67% | Terence Flynn66% | $182 → $182 | Reiterates | Overweight → Overweight | Get Alert |
| 05/12/2023 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | 27.39% | Terence Flynn66% | $39 → $42 | Maintains | Underweight | Get Alert |
| 05/12/2023 | CCCC | Buy Now | C4 Therapeutics | $1.30 | 130.77% | Terence Flynn66% | $5 → $3 | Maintains | Underweight | Get Alert |
| 05/12/2023 | ARVN | Buy Now | Arvinas | $6.57 | 432.72% | Terence Flynn66% | $38 → $35 | Maintains | Equal-Weight | Get Alert |
| 05/10/2023 | RPRX | Buy Now | Royalty Pharma | $31.00 | 67.74% | Terence Flynn66% | $50 → $52 | Maintains | Overweight | Get Alert |
| 05/08/2023 | OGN | Buy Now | Organon | $13.05 | 91.6% | Terence Flynn66% | $26 → $25 | Maintains | Equal-Weight | Get Alert |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $6.59 | 1205.01% | Terence Flynn66% | $83 → $86 | Maintains | Overweight | Get Alert |
| 04/28/2023 | ABBV | Buy Now | AbbVie | $186.99 | -2.67% | Terence Flynn66% | $181 → $182 | Maintains | Overweight | Get Alert |
| 04/19/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 19.19% | Terence Flynn66% | $179 → $183 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | UTHR | Buy Now | United Therapeutics | $292.46 | 8.05% | Terence Flynn66% | $320 → $316 | Maintains | Overweight | Get Alert |
| 04/10/2023 | RPRX | Buy Now | Royalty Pharma | $31.00 | 61.29% | Terence Flynn66% | $48 → $50 | Maintains | Overweight | Get Alert |
| 04/10/2023 | PFE | Buy Now | Pfizer | $22.93 | 91.89% | Terence Flynn66% | $45 → $44 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 16.58% | Terence Flynn66% | $180 → $179 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | LLY | Buy Now | Eli Lilly | $717.01 | -37.52% | Terence Flynn66% | $444 → $448 | Maintains | Overweight | Get Alert |
| 04/10/2023 | ABBV | Buy Now | AbbVie | $186.99 | -3.2% | Terence Flynn66% | $178 → $181 | Maintains | Overweight | Get Alert |
| 03/01/2023 | LLY | Buy Now | Eli Lilly | $717.01 | -38.08% | Terence Flynn66% | $455 → $444 | Maintains | Overweight | Get Alert |
| 02/27/2023 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | 18.29% | Terence Flynn66% | $37 → $39 | Maintains | Underweight | Get Alert |
| 02/27/2023 | CCCC | Buy Now | C4 Therapeutics | $1.30 | 284.62% | Terence Flynn66% | $6 → $5 | Maintains | Underweight | Get Alert |
| 02/27/2023 | ARVN | Buy Now | Arvinas | $6.57 | 447.95% | Terence Flynn66% | $57 → $36 | Maintains | Equal-Weight | Get Alert |
| 02/23/2023 | UTHR | Buy Now | United Therapeutics | $292.46 | 9.42% | Terence Flynn66% | $330 → $320 | Maintains | Overweight | Get Alert |
| 02/10/2023 | ABBV | Buy Now | AbbVie | $186.99 | -4.81% | Terence Flynn66% | $182 → $178 | Maintains | Overweight | Get Alert |
| 02/03/2023 | MRK | Buy Now | Merck & Co | $81.60 | 21.32% | Terence Flynn66% | $100 → $99 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | LLY | Buy Now | Eli Lilly | $717.01 | -36.54% | Terence Flynn66% | $440 → $455 | Maintains | Overweight | Get Alert |
| 02/03/2023 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 13.19% | Terence Flynn66% | $60 → $62 | Maintains | Underweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $22.93 | 96.25% | Terence Flynn66% | $53 → $45 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 17.23% | Terence Flynn66% | $176 → $180 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | $25 → $26 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | PFE | Buy Now | Pfizer | $22.93 | 131.14% | Terence Flynn66% | $51 → $53 | Maintains | Equal-Weight | Get Alert |
| 12/14/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -38.63% | Terence Flynn66% | $446 → $440 | Maintains | Overweight | Get Alert |
| 12/06/2022 | UTHR | Buy Now | United Therapeutics | $292.46 | 12.84% | Terence Flynn66% | $322 → $330 | Maintains | Overweight | Get Alert |
| 12/06/2022 | RPRX | Buy Now | Royalty Pharma | $31.00 | 64.52% | Terence Flynn66% | $54 → $51 | Maintains | Overweight | Get Alert |
| 12/06/2022 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 14.63% | Terence Flynn66% | $178 → $176 | Maintains | Equal-Weight | Get Alert |
| 12/06/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -37.8% | Terence Flynn66% | $436 → $446 | Maintains | Overweight | Get Alert |
| 12/01/2022 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 15.93% | Terence Flynn66% | $170 → $178 | Maintains | Equal-Weight | Get Alert |
| 11/17/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -39.19% | Terence Flynn66% | $441 → $436 | Maintains | Overweight | Get Alert |
| 11/11/2022 | ARVN | Buy Now | Arvinas | $6.57 | 767.58% | Terence Flynn66% | $63 → $57 | Maintains | Equal-Weight | Get Alert |
| 11/09/2022 | RPRX | Buy Now | Royalty Pharma | $31.00 | 74.19% | Terence Flynn66% | $51 → $54 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | $27 → $25 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | OGN | Buy Now | Organon | $13.05 | 83.93% | Terence Flynn66% | $27 → $24 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | NTLA | Buy Now | Intellia Therapeutics | $6.59 | 1159.48% | Terence Flynn66% | $84 → $83 | Maintains | Overweight | Get Alert |
| 11/03/2022 | BPMC | Buy Now | Blueprint Medicines | $81.68 | 32.22% | Terence Flynn66% | $143 → $108 | Maintains | Buy | Get Alert |
| 11/03/2022 | UTHR | Buy Now | United Therapeutics | $292.46 | 10.1% | Terence Flynn66% | $288 → $322 | Maintains | Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $22.93 | 122.42% | Terence Flynn66% | $50 → $51 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -38.49% | Terence Flynn66% | $408 → $441 | Maintains | Overweight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $81.60 | 22.55% | Terence Flynn66% | $91 → $100 | Maintains | Equal-Weight | Get Alert |
| 10/27/2022 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 9.54% | Terence Flynn66% | $61 → $60 | Maintains | Underweight | Get Alert |
| 10/19/2022 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 10.72% | Terence Flynn66% | $174 → $170 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | OGN | Buy Now | Organon | $13.05 | 106.93% | Terence Flynn66% | $35 → $27 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | MRK | Buy Now | Merck & Co | $81.60 | 11.52% | Terence Flynn66% | $92 → $91 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 13.33% | Terence Flynn66% | $173 → $174 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -43.1% | Terence Flynn66% | $412 → $408 | Maintains | Overweight | Get Alert |
| 10/12/2022 | PFE | Buy Now | Pfizer | $22.93 | 118.05% | Terence Flynn66% | $49 → $50 | Maintains | Equal-Weight | Get Alert |
| 10/11/2022 | NRIX | Buy Now | Nurix Therapeutics | $9.50 | 15.79% | Terence Flynn66% | → $11 | Initiates | → Equal-Weight | Get Alert |
| 10/11/2022 | NTLA | Buy Now | Intellia Therapeutics | $6.59 | 1174.66% | Terence Flynn66% | → $84 | Initiates | → Overweight | Get Alert |
| 10/11/2022 | UTHR | Buy Now | United Therapeutics | $292.46 | -1.52% | Terence Flynn66% | → $288 | Initiates | → Overweight | Get Alert |
| 10/11/2022 | RCUS | Buy Now | Arcus Biosciences | $6.87 | 482.24% | Terence Flynn66% | → $40 | Initiates | → Overweight | Get Alert |
| 10/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $32.97 | 12.22% | Terence Flynn66% | → $37 | Initiates | → Underweight | Get Alert |
| 10/11/2022 | CCCC | Buy Now | C4 Therapeutics | $1.30 | 361.54% | Terence Flynn66% | → $6 | Initiates | → Underweight | Get Alert |
| 10/11/2022 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | → $27 | Initiates | → Equal-Weight | Get Alert |
| 09/14/2022 | ABBV | Buy Now | AbbVie | $186.99 | 0.54% | Terence Flynn66% | → $188 | Reiterates | → Overweight | Get Alert |
| 09/12/2022 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 12.67% | Terence Flynn66% | $174 → $173 | Maintains | Equal-Weight | Get Alert |
| 09/07/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -42.54% | Terence Flynn66% | $395 → $412 | Maintains | Overweight | Get Alert |
| 08/08/2022 | RPRX | Buy Now | Royalty Pharma | $31.00 | 64.52% | Terence Flynn66% | $48 → $51 | Maintains | Overweight | Get Alert |
| 08/03/2022 | BPMC | Buy Now | Blueprint Medicines | $81.68 | 75.07% | Terence Flynn66% | $126 → $143 | Maintains | Buy | Get Alert |
| 07/29/2022 | MRK | Buy Now | Merck & Co | $81.60 | 12.75% | Terence Flynn66% | $88 → $92 | Maintains | Equal-Weight | Get Alert |
| 07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 11.36% | Terence Flynn66% | $63 → $61 | Maintains | Underweight | Get Alert |
| 07/08/2022 | PFE | Buy Now | Pfizer | $22.93 | 113.69% | Terence Flynn66% | $52 → $49 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | OGN | Buy Now | Organon | $13.05 | 160.57% | Terence Flynn66% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | MRK | Buy Now | Merck & Co | $81.60 | 7.84% | Terence Flynn66% | $87 → $88 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | JNJ | Buy Now | Johnson & Johnson | $153.54 | 13.33% | Terence Flynn66% | $173 → $174 | Maintains | Equal-Weight | Get Alert |
| 07/08/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -44.91% | Terence Flynn66% | $369 → $395 | Maintains | Overweight | Get Alert |
| 07/08/2022 | ABBV | Buy Now | AbbVie | $186.99 | 2.14% | Terence Flynn66% | $188 → $191 | Maintains | Overweight | Get Alert |
| 05/09/2022 | ARVN | Buy Now | Arvinas | $6.57 | 874.12% | Terence Flynn66% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 15.01% | Terence Flynn66% | $64 → $63 | Maintains | Underweight | Get Alert |
| 04/29/2022 | MRK | Buy Now | Merck & Co | $81.60 | 6.62% | Terence Flynn66% | $80 → $87 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -48.54% | Terence Flynn66% | $364 → $369 | Maintains | Overweight | Get Alert |
| 04/06/2022 | OGN | Buy Now | Organon | $13.05 | 168.24% | Terence Flynn66% | $37 → $35 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | MRK | Buy Now | Merck & Co | $81.60 | -1.96% | Terence Flynn66% | $82 → $80 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | LLY | Buy Now | Eli Lilly | $717.01 | -49.23% | Terence Flynn66% | $265 → $364 | Maintains | Overweight | Get Alert |
| 04/06/2022 | ABBV | Buy Now | AbbVie | $186.99 | 2.68% | Terence Flynn66% | $142 → $192 | Maintains | Overweight | Get Alert |
| 04/06/2022 | RPRX | Buy Now | Royalty Pharma | $31.00 | 54.84% | Terence Flynn66% | $46 → $48 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/06/2022 | BMY | Buy Now | Bristol-Myers Squibb | $54.78 | 16.84% | Terence Flynn66% | $66 → $64 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 04/06/2022 | ARVN | Buy Now | Arvinas | $6.57 | 889.35% | Terence Flynn66% | → $65 | Initiates | → Equal-Weight | Get Alert |
| 07/19/2021 | BHG | Buy Now | Bright Health Gr | — | — | Terence Flynn66% | → $2880 | Initiates | → Buy | Get Alert |
| 06/14/2021 | BIIB | Buy Now | Biogen | $123.00 | 254.47% | Terence Flynn66% | $246 → $436 | Maintains | Neutral | Get Alert |
| 06/14/2021 | LLY | Buy Now | Eli Lilly | $717.01 | -62.34% | Terence Flynn66% | $252 → $270 | Maintains | Buy | Get Alert |
| 06/03/2021 | OGNw | Buy Now | Organon | — | — | Terence Flynn66% | → $35 | Initiates | → Neutral | Get Alert |
| 11/19/2020 | PFE | Buy Now | Pfizer | $22.93 | 74.44% | Terence Flynn66% | → $40 | Reinstates | → Neutral | Get Alert |
| 10/05/2020 | TBIO | Buy Now | Telesis Bio | $0.43 | 4318.6% | Terence Flynn66% | → $342 | Initiates | → Buy | Get Alert |
| 08/03/2020 | MRK | Buy Now | Merck & Co | $81.60 | 28.68% | Terence Flynn66% | $91 → $105 | Upgrade | Neutral → Buy | Get Alert |
| 03/23/2020 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | $32 → $15 | Downgrade | Buy → Neutral | Get Alert |
| 03/11/2020 | LLY | Buy Now | Eli Lilly | $717.01 | -76.57% | Terence Flynn66% | → $168 | Maintains | Buy | Get Alert |
| 12/02/2019 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | → $25 | Initiates | → Buy | Get Alert |
| 05/29/2019 | XLRN | Buy Now | Acceleron Pharma | — | — | Terence Flynn66% | → $54 | Assumes | → Neutral | Get Alert |
| 05/28/2019 | LLY | Buy Now | Eli Lilly | $717.01 | -81.17% | Terence Flynn66% | → $135 | Initiates | → Buy | Get Alert |
| 05/23/2019 | BPMC | Buy Now | Blueprint Medicines | $81.68 | 53.04% | Terence Flynn66% | → $125 | Assumes | → Buy | Get Alert |
| 06/29/2018 | XLRN | Buy Now | Acceleron Pharma | — | — | Terence Flynn66% | $21 → $40 | Upgrade | Sell → Neutral | Get Alert |
| 03/05/2018 | RVNC | Buy Now | Revance Therapeutics | — | — | Terence Flynn66% | → $60 | Initiates | → Buy | Get Alert |
| 10/02/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.72 | — | Terence Flynn66% | — | Upgrade | Neutral → Buy | Get Alert |
| 08/16/2017 | BIIB | Buy Now | Biogen | $123.00 | — | Terence Flynn66% | — | Upgrade | Buy → Conviction Buy | Get Alert |
| 07/26/2017 | BIIB | Buy Now | Biogen | $123.00 | — | Terence Flynn66% | — | Upgrade | Neutral → Buy | Get Alert |
| 07/21/2017 | FGEN | Buy Now | FibroGen | $0.27 | — | Terence Flynn66% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/17/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Terence Flynn66% | → $20 | Initiates | → Sell | Get Alert |
| 03/13/2017 | BPMC | Buy Now | Blueprint Medicines | $81.68 | — | Terence Flynn66% | — | Upgrade | Neutral → Buy | Get Alert |
| 03/13/2017 | BIVV | Buy Now | Bioverativ | — | — | Terence Flynn66% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/06/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.72 | -85.45% | Terence Flynn66% | $65 → $34 | Maintains | Neutral | Get Alert |
